eClerx Included in ‘The Business Process Outsourcing Services Landscape, Q2 2026’ Report by Independent Research Firm
NEW YORK–(BUSINESS WIRE)–#AI–eClerx Services Ltd (ECLERX.NS), a global leader in AI-powered analytics, digital operations, automation, and business... Read more.
Nucleus Software Deepens Indonesia Presence Through Strategic Partnership with Azentra Solusi Digital
Building on nearly two decades of market presence, the collaboration strengthens local execution capabilities to accelerate lending and transaction banking transformation... Read more.
Sheppard Continues Private Equity Expansion with London Partner Gideon Sharp
Sharp Appointed London Office Managing Partner LONDON–(BUSINESS WIRE)–Sheppard is pleased to announce that senior partner Gideon Sharp has joined the... Read more.
Vertex Presents New Data on CASGEVY®, Including First European Presentation of Data in Children Ages 5–11, at the European Hematology Association Congress and Announces Additional Global Regulatory Submissions
– Data from pivotal studies of CASGEVY in children ages 5–11 with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrate transformative... Read more.
ACI Worldwide Powers Next-Generation PSP Expansion in Africa with Kwik Payments Go-Live
Kwik Payments utilizes ACI’s Payments Orchestration Platform to help merchants reduce checkout friction and drive conversion uplifts of more than 20% OMAHA, Neb.... Read more.
Oasis Welcomes ISS & Glass Lewis Support for Removal of KADOKAWA CEO Natsuno (Securities Code: 9468 JT)
*Leading proxy advisors ISS and Glass Lewis recommend shareholders vote AGAINST the re-election of CEO Takeshi Natsuno and FOR Oasis’s shareholder proposal to... Read more.
FDA Grants Priority Review for Genentech’s Tecentriq for a Certain Type of Stage III Colon Cancer
Filing acceptance is based on the Phase III Alliance ATOMIC study showing Tecentriq plus chemotherapy reduced recurrence or death risk by 50% versus chemotherapy... Read more.
FDA Grants Priority Review for Genentech’s Tecentriq for a Certain Type of Stage III Colon Cancer
Filing acceptance is based on the Phase III Alliance ATOMIC study showing Tecentriq plus chemotherapy reduced recurrence or death risk by 50% versus chemotherapy... Read more.
BW LPG Limited – Ex-dividend on the Oslo Stock Exchange Today
SINGAPORE–(BUSINESS WIRE)–With reference to the press release dated 2 June 2026 by BW LPG Limited (“BW LPG” or the “Company”, OSE ticker code:... Read more.
Galderma Unveils New Global Survey Data Exploring the Evolving Expectations and Experiences of Patients and Healthcare Professionals With Anti-wrinkle Treatments
Results from Galderma’s global survey showed that performance is the top priority for healthcare professionals (HCPs), with long-lasting results, pure, highly... Read more.